Biib stock price target

Biogen (NASDAQ:BIIB) Price Target Raised to $392.00 ... Biogen (NASDAQ:BIIB) had its target price upped by Nomura from $320.00 to $392.00 in a research note published on Friday morning, The Fly reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other equities research analysts …

Mar 27, 2020 · Online Stock Comparison - Compare Biogen Inc. (BIIB) to four other stocks with NASDAQ.com's stock comparison tool. Biogen Inc. [BIIB] stock Initiated by Barclays analyst ... The new note on the price target was released on January 27, 2020, representing the official price target for Biogen Inc. stock. Previously, the target price had yet another raise from $260 to $300, while Credit Suisse kept a Neutral rating on BIIB stock. Ride Out The Next Market Storm With ServiceNow Inc. (NYSE ...

Ride Out The Next Market Storm With ServiceNow Inc. (NYSE ...

23 Oct 2019 he said raising his 12-month price target to $365. That's about $140 above where shares were trading before Tuesday's announcement. 12 Jul 2018 BIIB Stock Forecast: Biogen Inc. Skyrockets As New Drug Brings According to the Alzheimer's Association, Alzheimer's care costs will be over  BIIB Price Target and Analyst Ratings (Biogen) | MarketBeat Nov 09, 2019 · 31 Wall Street analysts have issued ratings and price targets for Biogen in the last 12 months. Their average twelve-month price target is $325.40, suggesting that the stock has a possible upside of 9.81%. The high price target for BIIB is $410.00 and the low price target for BIIB is $231.00. BIIB Price Target | Biogen Stock Forecast & Ratings See Biogen price target based on 25 analysts offering 12 month price targets for Biogen in the last 3 months. The average price target is $342.91 with a high forecast of $420.00 and a low forecast of $282.00. The average price target represents a 16.93% increase from the last price of $293.27.

Apr 05, 2018 · Biotech stock Biogen (BIIB) drastically underperfomed in the first three months of the year and Barclays sees limited upside ahead Biogen Stock Hit With $100 Price-Target Cut After Ugly Q1

Biogen (NASDAQ:BIIB) had its target price boosted by Oppenheimer from to in a research report sent to investors on Friday, The Fly reports. A number of other equities research analysts also Why Investors Need To Watch Biogen Inc. (BIIB)? | News Heater Mar 04, 2020 · BIIB Stock Insider Trading. Reports are indicating that there were more than several insider trading activities at Biogen Inc. (BIIB), starting from Posner Brian S, who sold 1,055 shares at the price of $292.35 back on Dec 02. After this action, Rushing now owns 6,995 shares of Biogen Inc., valued at $308,429 with the latest closing price. Biogen Price Target | BIIB

The stock had previously closed at $317.95. Several equities research analysts have issued reports on the company. Credit Suisse Group lifted their price target on Biogen from $300.00 to $330.00 and gave the stock a “neutral” rating in a research note on Thursday, February 6th.

BIIB | Biogen Inc. Analyst Estimates & Rating – WSJ BIIB updated stock price target summary. Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Biogen Inc. (BIIB) Analyst Ratings, Estimates & Forecasts ... See Biogen Inc. (BIIB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Biogen Reaches Analyst Target Price | Nasdaq Jan 10, 2020 · In recent trading, shares of Biogen Inc (Symbol: BIIB) have crossed above the average analyst 12-month target price of $293.96, changing hands for $294.30/share. When a …

See Biogen price target based on 25 analysts offering 12 month price targets for Biogen in the last 3 months. The average price target is $342.91 with a high forecast of $420.00 and a low forecast of $282.00. The average price target represents a 16.93% increase from the last price of $293.27.

See Biogen price target based on 25 analysts offering 12 month price targets for Biogen in the last 3 months. The average price target is $342.91 with a high forecast of $420.00 and a low forecast of $282.00. The average price target represents a 16.93% increase from the last price of $293.27. Biogen Inc. Common Stock (BIIB) Analyst Research | Nasdaq Based on analysts offering 12 month price targets for BIIB in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your BIIB Stock Price | Biogen Inc. Stock Quote (U.S.: Nasdaq ...

BIIB | Biogen Inc. Stock Price & News - WSJ View the latest Biogen Inc. (BIIB) stock price, news, historical charts, analyst ratings and financial information from WSJ. Dow Jones, a News Corp company. Barclays Initiated Biogen Inc. [BIIB]. What else is Wall ...